Many BCR-ABL1 compound mutations reported in chronic myeloid leukemia patients may actually be artifacts due to PCR-mediated recombination

Affiliations

• ¹ Department of Genetics and Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia School of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia.
• ² Department of Genetics and Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia.
• ³ Departments of Genetics and Molecular Pathology and Hematology, Centre for Cancer Biology, SA Pathology, Adelaide, AustraliaSchool of Medicine, University of Adelaide, Adelaide, Australia.
• ⁴ Department of Hematology, Centre for Cancer Biology, SA Pathology, Adelaide, AustraliaSchool of Medicine, University of Adelaide, Adelaide, AustraliaCancer Theme, South Australian Health and Medical Research Institute, Adelaide, Australia.
• ⁵ Department of Genetics and Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide, AustraliaSchools of Medicine and Molecular and Biomedical Science, University of Adelaide, Adelaide, AustraliaSchool of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia.